• Contact
Augurex
  • Solutions
    • Solution Portfolio
    • Rheumatoid Arthritis
    • Axial Spondyloarthritis
    • Find a Test
  • Science
  • About
    • Company
    • Leadership
  • News
  • Careers
Select Page
Augurex Life Sciences Corp. Announces the Launch of the 14-3-3eta Test for Rheumatoid Arthritis Diagnosis and Monitoring with Sonic Reference Laboratory

Augurex Life Sciences Corp. Announces the Launch of the 14-3-3eta Test for Rheumatoid Arthritis Diagnosis and Monitoring with Sonic Reference Laboratory

by George Ciuciureanu | Nov 17, 2025 | Events, Health

Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid arthritis. The 14-3-3eta test will launch at Sonic Reference Laboratory...
Augurex to Exhibit and Present New Data on Anti-14-3-3eta Multiplex in Axial Spondyloarthritis at ACR Convergence 2025

Augurex to Exhibit and Present New Data on Anti-14-3-3eta Multiplex in Axial Spondyloarthritis at ACR Convergence 2025

by George Ciuciureanu | Oct 17, 2025 | Events, Health

Vancouver, Canada – October 17, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that it will be exhibiting at Booth 919 and presenting new data at the American College of Rheumatology (ACR) Convergence 2025, taking...
Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx

Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx

by George Ciuciureanu | Oct 15, 2025 | Events, Health

Augurex has partnered with MitogenDx to expand access to JOINTstat® testing across Canada, improving physician and patient access to advanced tools for rheumatoid arthritis (RA) diagnosis and monitoring. JOINTstat® is a Health Canada-approved Class II in vitro...
Augurex Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025

Augurex Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025

by George Ciuciureanu | Sep 24, 2025 | Events, Health

Augurex to present new data from clinical studies in an oral presentation and two poster presentations at ACR Convergence 2025, taking place October 24 – 29 in Chicago, IL. Professor Raj Sengupta will present new data in on the use of autoantibodies to 14-3-3eta in...
Augurex to Exhibit and Present New Data at CCR West 2025

Augurex to Exhibit and Present New Data at CCR West 2025

by George Ciuciureanu | Sep 8, 2025 | Events, Health

Vancouver, Canada – September 8, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced it will exhibit and present new data at the Congress of Clinical Rheumatology West (CCR West) 2025, taking place September 18–21 in...
Augurex to Exhibit and Sponsor Industry Lunch Seminar at the AMLI 2025 Annual Meeting

Augurex to Exhibit and Sponsor Industry Lunch Seminar at the AMLI 2025 Annual Meeting

by George Ciuciureanu | Aug 5, 2025 | Events, Health

Vancouver, Canada – August 5, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced its participation in the Association of Medical Laboratory Immunologists (AMLI) 38th Annual Meeting, taking place August 14–17 at the Hyatt...
Page 1 of 41234»
©2024 Augurex Life Sciences. All Rights Reserved. Website by Vanooms Media Inc.